Vivek Jain - 06 Mar 2023 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
Chairman and CEO, Director
Signature
By: Paula Darbyshire, Attorney-in-fact For: Vivek Jain
Issuer symbol
ICUI
Transactions as of
06 Mar 2023
Net transactions value
-$1,473,087
Form type
4
Filing time
08 Mar 2023, 15:56:38 UTC
Previous filing
31 May 2022
Next filing
18 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 +1,773 +11% $0.000000 17,242 06 Mar 2023 Direct F1
transaction ICUI Common Stock Tax liability $150,446 -933 -5.4% $161.25 16,309 06 Mar 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +9,994 +61% $0.000000 26,303 06 Mar 2023 Direct
transaction ICUI Common Stock Tax liability $848,336 -5,261 -20% $161.25 21,042 06 Mar 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +3,218 +15% $0.000000 24,260 07 Mar 2023 Direct F1
transaction ICUI Common Stock Tax liability $266,754 -1,694 -7% $157.47 22,566 07 Mar 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +2,525 +11% $0.000000 25,091 08 Mar 2023 Direct F1
transaction ICUI Common Stock Tax liability $207,550 -1,329 -5.3% $156.17 23,762 08 Mar 2023 Direct
holding ICUI Common Stock 60,000 06 Mar 2023 by Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 -1,773 -100% $0.000000* 0 06 Mar 2023 Common Stock 1,773 $0.000000 Direct F1, F3, F4, F5
transaction ICUI Common Stock Options Exercise $0 -2,525 -50% $0.000000 2,525 08 Mar 2023 Common Stock 2,525 $0.000000 Direct F1, F3, F4, F5
transaction ICUI Common Stock Options Exercise $0 -3,218 -33% $0.000000 6,436 07 Mar 2023 Common Stock 3,218 $0.000000 Direct F1, F3, F4, F5
transaction ICUI Performance Shares Options Exercise $0 -9,994 -100% $0.000000* 0 06 Mar 2023 Common Stock 9,994 Direct F6, F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are Restricted Stock Units.
F2 This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.
F3 There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F4 One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F5 These are restricted stock units that fully vest 3 years from the grant date.
F6 These Securities are Performance-based Restricted Stock Units (PRSU).
F7 There is neither a purchase price nor an exercise price for the PRSUs.
F8 These PRSUs were granted on March 6, 2020 and were subject to the satisfaction of both performance-based and time-based criteria. These PRSUs had a 3-year performance period and cliff-vested on the third anniversary of the grant date.